ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
AANS 2019 Intrasaccular Device Effective, Safe for Difficult Aneurysms The Woven EndoBridge Intrasaccular Therapy device (WEB) proved safe and effective for treating wide-neck bifurcation aneurysms in ...
The WEB device is the world's first intrasaccular flow disruptor, designed to treat brain aneurysms from inside the aneurysm sac. Unlike traditional treatments for wide-neck bifurcation aneurysms that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback